Neogen Corporation - Asset Resilience Ratio
Neogen Corporation (NEOG) has an Asset Resilience Ratio of 0.00% as of May 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Neogen Corporation for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2025)
This chart shows how Neogen Corporation's Asset Resilience Ratio has changed over time. See Neogen Corporation book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Neogen Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Neogen Corporation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Neogen Corporation maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Neogen Corporation Industry Peers by Asset Resilience Ratio
Compare Neogen Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Fleury S.A.
SA:FLRY3 |
Diagnostics & Research | 16.19% |
|
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060 |
Diagnostics & Research | 2.10% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Avricore Health Inc
V:AVCR |
Diagnostics & Research | 0.75% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
Annual Asset Resilience Ratio for Neogen Corporation (1999–2025)
The table below shows the annual Asset Resilience Ratio data for Neogen Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-05-31 | 0.00% | $0.00 | $3.44 Billion | -- |
| 2024-05-31 | 0.01% | $325.00K | $4.55 Billion | -1.80pp |
| 2023-05-31 | 1.81% | $82.33 Million | $4.55 Billion | -32.09pp |
| 2022-05-31 | 33.90% | $336.58 Million | $992.93 Million | +0.70pp |
| 2021-05-31 | 33.20% | $305.49 Million | $920.19 Million | -1.60pp |
| 2020-05-31 | 34.80% | $277.40 Million | $797.18 Million | +2.34pp |
| 2019-05-31 | 32.46% | $225.84 Million | $695.74 Million | +11.79pp |
| 2018-05-31 | 20.67% | $127.74 Million | $618.01 Million | +8.17pp |
| 2017-05-31 | 12.50% | $66.07 Million | $528.41 Million | +0.87pp |
| 2016-05-31 | 11.63% | $52.54 Million | $451.71 Million | -0.63pp |
| 2015-05-31 | 12.27% | $48.10 Million | $392.18 Million | +1.89pp |
| 2014-05-31 | 10.37% | $35.82 Million | $345.30 Million | -1.84pp |
| 2013-05-31 | 12.22% | $35.34 Million | $289.25 Million | +4.43pp |
| 2012-05-31 | 7.79% | $19.60 Million | $251.60 Million | -1.42pp |
| 2011-05-31 | 9.21% | $20.24 Million | $219.66 Million | +9.04pp |
| 2006-05-31 | 0.17% | $150.00K | $88.29 Million | -0.38pp |
| 2004-05-31 | 0.55% | $331.00K | $59.98 Million | -15.76pp |
| 2003-05-31 | 16.31% | $7.84 Million | $48.04 Million | +5.43pp |
| 2002-05-31 | 10.88% | $4.34 Million | $39.90 Million | -8.30pp |
| 2001-05-31 | 19.18% | $6.33 Million | $33.02 Million | -9.51pp |
| 2000-05-31 | 28.69% | $8.47 Million | $29.53 Million | -8.09pp |
| 1999-05-31 | 36.78% | $9.60 Million | $26.10 Million | -- |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne path… Read more